A Phase 1b clinical trial to evaluate the safety and efficacy of BCMA-targeted CAR T-cell therapy in Thai patients with relapsed or refractory multiple myeloma.

August 23, 2025
Chulalongkorn Univeristy

Research Topics Antitumor activities of chimeric antigen receptor T cells targeting Mucin-1 with self-released anti-PD-1 IgG antibody Researchers Dr.Koramit Suppipat Institute Multicenter Clinical Trials Funding PMU-C Timeline 2026-2028 Facebook...

Registration Open: 1st International Scientific Symposium in Hematologic Malignancy (CETH, Chulalongkorn University)

August 17, 2025
Chiang Mai University, Chulalongkorn University, Events, Khonkaen University, Mahidol University, Prince of Songkla University

Registration Open – 1st International Scientific Symposium in Hematologic Malignancy The Center of Excellence in Translational Hematology (CETH), Faculty of Medicine, Chulalongkorn University, is pleased to announce the 1st...

A multi-center clinical research project to study the Safety and Efficacy of CD19 CAR T-cells in ALL (Acute Lymphoblastic Leukemia) by Academic Hubs

August 17, 2025
Chulalongkorn Univeristy

Research Topics A multi-center clinical research project to study the Safety and Efficacy of CD19 CAR T-cells in ALL (Acute Lymphoblastic Leukemia) by Academic Hubs Researchers Koramit Suppipat and...

Development of CAR T-cell Products for the Treatment of Hematologic Malignancies to Enhance the Competitiveness of Thailand’s Advanced Therapy Medicinal Products (ATMP) Industry (Phase 1)

August 17, 2025
Chulalongkorn Univeristy

Research Topics Development of CAR T-cell Products for the Treatment of Hematologic Malignancies to Enhance the Competitiveness of Thailand’s Advanced Therapy Medicinal Products (ATMP) Industry (Phase 1) Researchers Koramit...

Clinical research project on CAR T-cells in collaboration with a multi-institutional network (Academic CAR T-cell network).

August 17, 2025
Chulalongkorn Univeristy

Research Topics Clinical research project on CAR T-cells in collaboration with a multi-institutional network (Academic CAR T-cell network). Researchers Koramit Suppipat and TTCI team Institute Faculty of Medicine, Chulalongkorn...

Safety/Phase I study of PiggyBac transposon mediated Chimeric Antigen Receptor T cells targeting CD-19 in Thai patients with refractory systemic lupus Erythematosus

August 17, 2025
Chulalongkorn Univeristy

Research Topics Safety/Phase I study of PiggyBac transposon mediated Chimeric Antigen Receptor T cells targeting CD-19 in Thai patients with refractory systemic lupus Erythematosus Researchers Wannagam Kijthanamongkolchai Institute Faculty...

Expanding Horizons in Immunotherapy: Integrating Advanced Cell Engineering, Reprogramming, and Adjunct Therapies for Cancer and inflammatory-mediated diseases

August 17, 2025
Chulalongkorn Univeristy

Research Topics Expanding Horizons in Immunotherapy: Integrating Advanced Cell Engineering, Reprogramming, and Adjunct Therapies for Cancer and inflammatory-mediated diseases Researchers Prof.Nattiya Hirankarn and TTCI team Institute Faculty of Medicine,...

Enhancing Innate and Adaptive Immunity to Combat Multiple Myeloma: Combined Use of Trispecific NK Cell Engagers (TriKEs) and Bispecific T-Cell Engagers (BiTEs) in Immunotherapy

August 17, 2025
Chiang Mai University

Research Topics Enhancing Innate and Adaptive Immunity to Combat Multiple Myeloma: Combined Use of Trispecific NK Cell Engagers (TriKEs) and Bispecific T-Cell Engagers (BiTEs) in Immunotherapy Researchers Aussara PanyaNueng-hathai...

NRCT Hosts Seminar on “Thai Cancer Immunotherapy: Collaboration, Regulation, and the Future of Treatment” at MHESI Fair 2025

August 16, 2025
Chiang Mai University, Chulalongkorn University, Events, Khonkaen University, Mahidol University, Prince of Songkla University

Event Details I August 16th, 2025 Recorded VDO I August 16th, 2025 (Conference) Recorded VDO I August 16th, 2025 (Conference) Photo I August 16th, 2025 Event Details I August...

Clinical resolution of autoimmune choroiditis and multiorgan involvement of refractory systemic lupus erythematosus patient treated with CD19CAR-T incorporated CD28/CD40 signaling molecules

August 10, 2025
Prince of Songkla University

Research Topics Clinical resolution of autoimmune choroiditis and multiorgan involvement of refractory systemic lupus erythematosus patient treated with CD19CAR-T incorporated CD28/CD40 signaling molecules Researchers Jakrawadee Julamanee,Panarat Noiperm,Watsamon Uraiwan,Porntip Intapiboon,Parichat...